Back to Results
First PageMeta Content
Pharmaceuticals policy / Food and Drug Administration / Clinical pharmacology / United States Public Health Service / Pharmaceutical industry / New Drug Application / Economic shortage / Prescription medication / Pharmaceutical sciences / Pharmacology / Health


Permanent Discontinuance or Interruption in Manufacturing of Certain Drug or Biological Products; Proposed Rule
Add to Reading List

Open Document

File Size: 404,60 KB

Share Result on Facebook

Country

United States / /

Currency

USD / /

IndustryTerm

covered prescription drug products / recombinant product / covered prescription biological products / radiopharmaceutical products / biological products / drug product / medical products / prevention of a debilitating disease / treatment of a debilitating disease / cancer treatment / manufacturing / pharmaceutical / healthcare providers / manufacturing line / /

MedicalCondition

cancer / disease / clinical trials involving cancer / /

MedicalTreatment

medication errors / chemotherapy / surgery / medication error / /

Organization

Food and Drug Administration / FDA DSS / Center for Drug Evaluation and Research / DEPARTMENT OF HEALTH AND HUMAN SERVICES / Planning office of Policy / Planning Office / /

Person

Obama / /

Position

issued Executive / President / Commissioner / Executive / physician / representative / /

PublishedMedium

Public Law / the Drug Shortages Staff review / /

Technology

chemotherapy / /

SocialTag